GB1107 - HY-114409

Nur noch %1 verfügbar
Catalog #
HY-114409
Ab 162,00 €
GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a Kd of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic model[1].
Weitere Informationen
Datasheet URL http://file.medchemexpress.com/batch_PDF/HY-114409/GB1107-DataSheet-MedChemExpress.pdf
Shipping Blue Ice
Application Cancer-programmed cell death
CAS 1978336-61-6
Storage -20°C (Powder, stored under nitrogen)
MWT 522.32
Solubility DMSO : 50 mg/mL (ultrasonic)
Clinical Information No Development Reported
Target Galectin
Applications
Application: Cancer-programmed cell death

Newsletter
abonnieren

15% Rabatt

erhalten